2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Curative Correction of FAH Deficiency by Chimeric Stem Cells Transplantation

D. Joo,^1,2 E. Nelson,¹ Y. Zhang,¹ B. Amiot,¹ S. Ho,³ C. Lancto,⁴ D. Carlson,⁴ L. Queiroz,⁵ S. Nyberg.¹
CXCR4 Inhibition Improves Donor Leukocyte Depletion during Ex Vivo Lung Perfusion

R. Davis, Q. Gao, J. Yerxa, M. Daneshmand, J. Haney, J. Klapper, M. Hartwig, A. Barbas.
Cytokine Profiles in Children after Pediatric Kidney Transplantation with Acute and Chronic Rejection

T. Ahlenstiel-Grunow, N. Borsum, L. Pape.
Cytomegalovirus (CMV) Infection in Small Intestinal and Multivisceral Transplant Recipients: The Role of Donor Selection on CMV Incidence and Outcomes

H. Grewal, M. Czech, C. Matsumoto, M. Natarajan, J. Fraker, W. Fan, J. Timpone.
Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients and Role of Prophylaxis

G. Nance,¹ A. Serluco,¹ S. Deshpande,^2,1 R. Garro,^3,1 R. George,^3,1 M. Kelleman,³ R. Liverman.¹
Cytomegalovirus Prophylaxis Following Alemtuzumab Induction in High Risk Renal Transplant Recipients Experiencing Delayed Graft Function

S. Freedman, B. Ravichandran, B. Masters, E. Heil, K. Saharia, J. Bromberg, A. Haririan, T. Sparkes.
DAP12 and Its Triggering Co-Receptor TREM2 Play Key Roles in Regulation of Mouse and Human Liver DC Function and Control of Liver Ischemia-Reperfusion Injury

T. Nakao,¹ Y. Ono,¹ H. Dai,¹ A. Perez-Gutierrez,¹ G. Camirand,¹ H. Huang,¹ D. Geller,^1,2 A. Thomson.^1,3
Daptomycin Minimum Inhibitory Concentration (MIC) of Vancomycin Resistant Enterococcal (VRE) Blood Isolates Correlates with Allograft Failure in Orthotopic Liver Transplant (OLT) Recipients

R. Lee,¹ G. Haidar,² J. Lewis,³ S. Arif,⁴ J. Hand,⁵ E. Holaday,⁶ H. Clauss,⁶ J. Goldman,⁷ A. Nellore.¹
DCD Kidneys with Remuzzi Scores of 4-5 Can Be Accepted for Solitary Kidney Transplantation

X-.P. Yuan, C-.B. Chen, Y. Zheng, J. Zhou, C. Wang, X. He.
DCD Utilization in Cholestatic Liver Disease: Distinct Outcomes between PSC and PBC Recipients

J. Pasko, E. Maynard, E. Dewey, K. Roayaie, S. Orloff, D. Scott, W. Naugler, J. Ahn, C. Enestvedt.

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z